Even a broken clock is right twice a day. All I am saying is Geron is yet to see it's highest share price. Topping out at 6.68 just a few weeks ago ... with over 50 mil trades in 1 day ... it's obvious people are watching. Sure a lot of them are shorts. But only time will tell who will be right on this one.
LFIN ,BITCF,TRTCD - was NEVER, NEVER - on FAST TRUCK from FDA ! (80% drugs from FDA FAST TRUCK - APROOVED !!! - Fact History )
NICE TRY..... Now I’m saying YOU SHORTED GERN , and losing a lot $$$$$$$. Your opinion Full scam .... You said - (Every biotech company does puts their pipeline drugs on its website. Nothing to read into. ) ??? What is it ?
Enjoy this information , but your time is gone . Yes, history repeat your short position will be burn , like NOK on sweet September 3 2013 .
P.s. While a buyout would be a great for Geron investors, there are many other catalysts besides a buyout that could cause the share price to jump. JNJ is currently slated to issue a continuation decision by Q3 of this year. In addition, the positive string of FDA decisions for Imetelstat (Orphan Drug designation and Fast Track status) and the promising preliminary clinical results that were announced in March 2018 are giving investors hope that Accelerated Approval or Break Through Designation might occur in the near future. Either of these events will likely cause the share price to spike and head north of $10 even without a buyout occurring.